We were interested to read the case report study 1 on two patients who had taken significant paracetamol overdoses presenting within 4 h post-ingestion and developing significant hypokalaemia within 8 h of presentation. Both cases received intravenous NAC treatment. The authors also reported hypokalaemia within 36 h of admission in 254 patients with paracetamol overdose. The potential effect of NAC therapy, acid-base change and stress on hypokalaemia was discussed. The authors recommended that although the possible mechanisms for hypokalaemia after paracetamol overdose are unclear, regular monitoring of serum potassium should be carried out over 36 h post-ingestion. Treatment of any significant hypokalaemia has also been suggested.
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We have published retrospective and prospective studies studying this phenomenon. 2 In our retrospective study, in 155 subjects who had taken single paracetamol overdoses and presented within 4 -6 h post-ingestion serum potassium change between admission to hospital (4 -6 h postingestion) and 24 h post-ingestion was studied. We showed a dose-dependent relationship between fall in serum potassium and serum paracetamol at presentation. No relationship was seen between serum paracetamol or serum bicarbonate and the same trend in potassium was seen in the group with and without NAC treatment.
To have a better understanding of the possible mechanism of potassium change after paracetamol overdose we then prospectively studied 41 subjects taking a single paracetamol overdose and presenting within 4 -6 h postingestion. We measured serum paracetamol at 4 h, and serum potassium (K) and fractional excretion of K (FeK) at 4 -6, 12 and 24 h. There was a significant dose-dependent relationship between serum paracetamol and FeK at 12 h. The FeK had returned to normal by 24 h. Our control group did not show changes in serum K or FeK. Studies on the rat 3 have shown paracetamol overdose causes a significant decrease in renal perfusion and an increase in FeK at 16 h which had normalized by 24 h.
Based on our studies and animal study, we concluded that paracetamol overdose is associated with dose-related hypokalaemia, and kaliuresis of short duration (,24 h), suggesting a specific renal effect of paracetamol in overdose perhaps via cyclo-oxygenase inhibition.
We appreciate the authors' enthusiasm for treating patients with significant hypokalaemia. However, both our data and animal data show that the renal effect of paracetamol overdose is transient and is resolved by 24 h postingestion. We believe a 36 h monitoring period is unnecessary and potentially wasteful of hospital resources. Interestingly, we did not find evidence that this renal effect of paracetamol was related to its well-recognized nephrotoxicity 4 in our cohort. Author's response to Pakravan et al.
We thank Drs Pakravan et al. for their commentary on our case report of two patients who had taken significant paracetamol overdoses and subsequently developed significant hypokalaemia within 8 h of presentation. 1 We would however like to make the following comments in reply:
We appreciate the authors' conviction with respect to their published retrospective and prospective studies relating to this phenomenon. 2 The authors have sought to extrapolate evidence gathered in an animal model, which certainly points towards a renal perfusion hypothesis as the cause of the hypokalaemia. Conclusive proof has however not yet been established that this model can be extrapolated into a human population.
The authors state that they believe a 36 h monitoring period is unnecessary and potentially wasteful of hospital resources for these patients. We would like to refute that claim as we believe it would be unwise from a clinical perspective to discharge a previously normokalaemic patient who had presented with this rare complication of paracetamol overdose back into the community immediately. The current level of evidence does not allow us to safely conclude that this hypokalaemia may be dismissed as unimportant in the context of their discharge from the hospital. Indeed a large number of our patients have concurrent cardiovascular pathology and addiction issues that may be significantly complicated by concurrent hypokalaemia. We would therefore advocate a more cautious approach until more robust evidence is available. Significant hypokalaemia remains an uncommon complication of the paracetamol toxidrome; it is therefore outside the norm and should be treated as such. Clinicians may find it hard to justify complications that arise in this group of patients, if discharged prior to normalization of their serum potassium concentration.
